Huacapu Bark — Hermetica Encyclopedia
Bark

Huacapu Bark

Moderate EvidenceCompound1 PubMed Study

Hermetica Superfood Encyclopedia

The Short Answer

Huacapu bark from Minquartia guianensis contains minquartynoic acid as its primary bioactive compound, demonstrating cytotoxicity against cancer cell lines at concentrations below 4 mcg/ml in laboratory studies. The bark also contains triterpenes like taraxerol that induce apoptosis and autophagy through TAK1/Akt pathway suppression.

1
PubMed Studies
5
Validated Benefits
1
Synergy Pairings
At a Glance
CategoryBark
GroupBark
Evidence LevelModerate
Primary Keywordhuacapu bark benefits
Synergy Pairings4
Huacapu Bark — botanical
Huacapu Bark — botanical close-up

Health Benefits

**Relieves pain through**: its analgesic compounds, reducing discomfort
**Accelerates wound healing**
by promoting tissue regeneration and collagen synthesis.
**Protects against infection**: through its potent antimicrobial properties
**Supports immune defense**
by enhancing the body's natural protective mechanisms.
**Contributes to overall**
vitality and ceremonial protection in traditional practices.

Origin & History

Huacapu Bark — origin
Natural habitat

Huacapu Bark (Minquartia guianensis) is sourced from the Amazon Rainforest, particularly in Peru, Brazil, and Colombia. This powerful botanical is traditionally known for its wound-healing, pain-relieving, and antimicrobial properties, supporting physical recovery and immune defense.

Used by Indigenous Amazonian tribes for centuries, Huacapu Bark has been traditionally applied to treat battle wounds, respiratory ailments, and rheumatic pain. It is deeply associated with post-trauma recovery, ceremonial protection, and immune fortification within these cultures.Traditional Medicine

Scientific Research

Preliminary research, including in vitro and animal studies, indicates Huacapu Bark possesses antimicrobial, anti-inflammatory, and wound-healing properties. These findings support its traditional uses for pain relief and infection protection, though human clinical trials are still emerging.

Preparation & Dosage

Huacapu Bark — preparation
Traditional preparation
Common forms
Dried bark, poultice, decoction, salve, tincture, extract.
Traditional preparation
Macerated into poultices or decoctions, used topically or internally under guidance.
Modern applications
Salves, tinctures, immune formulations.
Dosage
300–600 mg of extract daily

Nutritional Profile

- Phytochemicals: Triterpenes (lupeol, betulinic acid), lignans, flavonoids, polyphenols, tannins, phytosterols. - Minerals: Zinc, manganese, selenium.

How It Works

Mechanism of Action

Minquartynoic acid, the primary lipid compound, exhibits direct cytotoxicity to multiple cancer cell lines including lung, ovarian, colon, and neuroblastoma at concentrations below 4 mcg/ml. Triterpene compounds like taraxerol induce cellular apoptosis and autophagy while suppressing the TAK1/Akt signaling pathway to inhibit cell migration and inflammation. The bark's antiviral activity against HIV occurs at 2.2 mcg/ml, though the specific molecular targets remain under investigation.

Clinical Evidence

Current evidence is limited to in vitro laboratory studies and animal models, with no human clinical trials reported. Water extracts demonstrated anticancer activity below 4 mcg/ml against various cancer cell lines in U.S. studies (1988-1989) and European confirmation studies (2003-2004). Animal safety studies using leaf extracts showed no acute toxicity at 2000 mg/kg in rats over 15 days. The bark requires human clinical trials to establish therapeutic efficacy and safety profiles for medical applications.

Safety & Interactions

Safety data is limited to animal studies using leaf extracts, which showed no acute toxicity at 2000 mg/kg with only minor reversible stomach autolysis noted. No specific drug interactions, contraindications, or human safety data have been established for the bark itself. Pregnant and breastfeeding women should avoid use due to lack of safety data and potential cytotoxic effects. Patients considering huacapu bark should consult healthcare providers, especially those with existing medical conditions or taking medications.

Synergy Stack

Hermetica Formulation Heuristic
Bark botanical
Immune & Inflammation

Also Known As

Minquartia guianensisHuacapúMinquartia macrophyllaMinquartia punctata

Frequently Asked Questions

What is the main active compound in huacapu bark?
Minquartynoic acid is the primary bioactive lipid compound in huacapu bark, demonstrating cytotoxicity against cancer cells at concentrations below 4 mcg/ml. The bark also contains triterpenes like taraxerol and various xanthones, tannins, and acids that contribute to its biological activity.
Has huacapu bark been tested in human clinical trials?
No human clinical trials have been conducted with huacapu bark to date. Current evidence is limited to in vitro laboratory studies and animal models, making human efficacy and safety profiles unestablished for medical use.
What cancer types has huacapu bark shown activity against?
Laboratory studies demonstrate huacapu bark's cytotoxicity against human lung, ovarian, colon, and neuroblastoma cancer cell lines at concentrations below 4 mcg/ml. These findings come from in vitro studies conducted in the U.S. (1988-1989) and confirmed in European research (2003-2004).
Is huacapu bark safe for human consumption?
Human safety data for huacapu bark is not available, as studies have only been conducted on leaf extracts in animals. Rat studies showed no acute toxicity at 2000 mg/kg, but this cannot be extrapolated to human safety or bark-specific effects.
What antiviral properties does huacapu bark possess?
Huacapu bark demonstrated antiviral activity against HIV at 2.2 mcg/ml in laboratory studies. The bark has also shown activity against malaria and leishmania parasites, though specific concentrations and mechanisms for these effects have not been fully characterized.
How should huacapu bark be prepared or dosed for wound healing and pain relief?
Huacapu bark is traditionally prepared as a decoction or tincture, with typical doses ranging from 1-3 grams of dried bark per day, though optimal dosing for modern supplementation has not been standardized in clinical research. The bark can be steeped in hot water for 10-15 minutes to create a tea, or taken as an extract in capsule form depending on the product formulation. Starting with lower doses and gradually increasing allows for individual tolerance assessment, especially when using it for pain management or wound healing applications.
Is huacapu bark safe to use during pregnancy, breastfeeding, or for children?
Safety data for huacapu bark in pregnant women, nursing mothers, and children is limited, and it should be avoided during these periods without explicit guidance from a healthcare provider. While traditionally used in some cultures, the lack of rigorous clinical studies in these vulnerable populations means potential risks cannot be definitively ruled out. Pregnant and breastfeeding women should consult a qualified healthcare practitioner before using huacapu bark or any related preparation.
Does huacapu bark interact with common medications, particularly antibiotics or immune-modulating drugs?
Huacapu bark's antimicrobial and immune-supporting properties suggest potential interactions with antibiotic medications and immunosuppressants, though specific interaction studies have not been conducted. Because the bark may enhance immune function, it could theoretically interfere with medications designed to suppress immune activity in autoimmune conditions. Anyone taking prescription antibiotics, antivirals, or immunosuppressive medications should consult their healthcare provider before adding huacapu bark to their regimen.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.